x
Breaking News
0

Amgen Inc (AMGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amgen's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
177.04 +2.12    +1.21%
15/12 - Closed. Currency in USD ( Disclaimer )
After Hours
177.60
+0.56
+0.32%
22:45:53 GMT - Real-time Data
Type: Equity
Market: United States
ISIN: US0311621009 
CUSIP: 031162100
  • Volume: 5,796,759
  • Bid/Ask: 177.10 / 177.60
  • Day's Range: 174.14 - 177.41
Start Trading
Amgen 177.04 +2.12 +1.21%

AMGN Overview

 
Information about the Amgen Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close174.92
Day's Range174.14 - 177.41
Revenue23.01B
Open176.39
52 wk Range145.12 - 191.1
EPS11.07
Volume5,796,759
Market Cap128.52B
Dividend (Yield)4.45 (2.98%)
Average Vol. (3m)2,659,956
P/E Ratio15.99
Beta1.36
1-Year Change18.52%
Shares Outstanding725,910,575
Next Earnings DateJan 31, 2018
What is your sentiment on Amgen?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Buy Buy Buy Strong Buy
Technical Indicators Strong Sell BUY Strong Buy Strong Buy Strong Buy
Summary Strong Sell Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Black Crows 15 Current
Engulfing Bearish 30 Current
Completed Patterns
Engulfing Bearish 1D 1 Dec 14, 2017
Bullish Engulfing 5H 1 Dec 15, 2017 10:00AM
Engulfing Bearish 1M 2 Oct 17

Amgen Inc News & Analysis

Amgen Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 177.04 177.10 177.60 5,796,759 +1.21% USD 15/12  
  Mexico 3,389.82 0.00 0.00 0 0.00% MXN 13/12  
  Switzerland 173.30 0.00 0.00 0 0% CHF 01/12  
  Berlin 150.75 150.64 151.38 0 +1.66% EUR 07:08:00  
  Frankfurt 150.66 150.64 151.40 300 +0.92% EUR 08:05:00  
  Xetra 151.50 150.55 151.45 15 +1.10% EUR 08:04:00  
  TradeGate 151.20 150.64 151.38 221 +0.58% EUR 07:14:00  
  Munich 150.55 150.43 152.66 0 +0.61% EUR 07:08:00  
  Stuttgart 150.64 150.64 151.33 0 +0.66% EUR 08:36:00  
  BM&FBovespa 585.75 0.00 0.00 0 0.00% BRL 12/12  
  Hong Kong 444.00 0.00 0.00 0 0.00% HKD 29/07  
  Vienna 149.875 0.000 0.000 0 0.00% EUR 15/12  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 173.97 174.17 172.46 +1.75 +1.02% 40.17M 15/12  
  SBI 320.65 323.50 300.40 +8.40 +2.69% 27.71M 08:55:14  
  Merck&Co 56.24 56.37 55.75 +0.23 +0.41% 22.58M 15/12  
  Alibaba 173.55 173.55 170.00 +1.80 +1.05% 41.36M 15/12  
  Amazon.com 1,179.14 1,182.75 1,169.33 +4.88 +0.42% 4.78M 15/12  
  Visa 113.82 114.20 112.39 +0.90 +0.80% 16.39M 15/12  
  Helios&Matheson 6.260 6.779 6.000 -0.440 -6.57% 4.37M 15/12  
  Tesla 343.45 343.90 335.76 +5.56 +1.65% 6.93M 15/12  
  Investor B 388.6 389.3 385.1 +5.5 +1.44% 197.49K 08:39:00  
  H&M B 165.2 173.3 164.9 -9.1 -5.22% 4.80M 08:39:00  

Amgen Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

19200

Equity Type

ORD

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Amgen Inc
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest AMGN Comments

anshum gupta
anshum gupta May 16, 2016 7:25AM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Possibility of a correction from the current levels, but it becomes a good buy in between 144.5-147.5 for the targets of 157.5/159.35/173.3/180. If kept from a longer term perspective, then ultimate target of 210 and above is possible. Keep a stop loss of below 137.5 on a monthly closing basis. Happy investing!!!!
Reply
0 0
Christian Heine
Christian Heine Oct 28, 2016 2:03PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The correction should have occured in after trades...speculative attack..
Reply
0 0
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email